← Leaderboards
Steven A. Fisher
Baltimore Va Medical Center
$11,374,322
Attributed
$12,444,954
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,444,954 · 8
VA$0 · 2
By mechanism
R01$11,756,884 · 4
T32$626,130 · 1
P41$61,940 · 3
I01$0 · 1
I21$0 · 1
Top collaborators
- Christopher V. Plowe4 shared
- Shannon Takala Harrison2 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesBlood VesselsMediatingSignal TransductionMolecularCyclic GmpIn VivoProtein IsoformsMuscle Relaxation PhaseCardiovascular SystemMyosin PhosphataseAnimal ModelC-TerminalAlternative SplicingExonsLeucine ZippersSignal PathwaySmooth MuscleCodePathway InteractionsFundingGene ExpressionResponseBlood Flow
Grant awards (45)
A splice blocking anti-sense oligonucleotide as a novel therapy for US Veterans with hypertension and heart failure (HFpEF)$0
I21 · FY2024 · VA · contact PI
Precision Editing of Myosin Phosphatase for Vasodilator Sensitization in Hypertension$347,625
R01 · FY2022 · HL · contact PI
Precision Editing of Myosin Phosphatase as a Novel Approach for Vasodilator Sensitization and Lowering of Blood Pressure in Hypertension$0
I01 · FY2022 · VA · contact PI
Precision Editing of Myosin Phosphatase for Vasodilator Sensitization in Hypertension$347,625
R01 · FY2021 · HL · contact PI
Precision Editing of Myosin Phosphatase as a Novel Approach for Vasodilator Sensitization and Lowering of Blood Pressure in Hypertension$0
I01 · FY2021 · VA · contact PI
Precision Editing of Myosin Phosphatase for Vasodilator Sensitization in Hypertension$347,625
R01 · FY2020 · HL · contact PI
Precision Editing of Myosin Phosphatase as a Novel Approach for Vasodilator Sensitization and Lowering of Blood Pressure in Hypertension$0
I01 · FY2020 · VA · contact PI
Precision Editing of Myosin Phosphatase for Vasodilator Sensitization in Hypertension$347,625
R01 · FY2019 · HL · contact PI
Precision Editing of Myosin Phosphatase as a Novel Approach for Vasodilator Sensitization and Lowering of Blood Pressure in Hypertension$0
I01 · FY2019 · VA · contact PI
Variant surface antigens in cerebral malaria pathogenesis$627,531
R01 · FY2018 · HL
Variant surface antigens in cerebral malaria pathogenesis$27,810
R01 · FY2018 · HL
Variant surface antigens in cerebral malaria pathogenesis$432,014
R01 · FY2017 · HL
NIH - NHLBI - Re-Entry Supplement to Existing R01 Variant surface antigens in cerebral malaria pathogenesis$146,775
R01 · FY2017 · HL
Variant surface antigens in cerebral malaria pathogenesis$430,243
R01 · FY2016 · HL
Variant surface antigens in cerebral malaria pathogenesis$476,891
R01 · FY2015 · HL
Smooth Muscle Myosin Phosphatase Subunit Isoforms$362,950
R01 · FY2013 · HL · contact PI
Tissue Hypoxia in Cardiac Morphogenesis$361,677
R01 · FY2013 · HL · contact PI
Training Grant in Cardiac and Vascular Cell Biology$268,547
T32 · FY2013 · HL · contact PI
Smooth Muscle Myosin Phosphatase Subunit Isoforms$381,250
R01 · FY2012 · HL · contact PI
Tissue Hypoxia in Cardiac Morphogenesis$379,913
R01 · FY2012 · HL · contact PI
Training Grant in Cardiac and Vascular Cell Biology$357,583
T32 · FY2012 · HL · contact PI
Tissue Hypoxia in Cardiac Morphogenesis$392,500
R01 · FY2011 · HL · contact PI
Smooth Muscle Myosin Phosphatase Subunit Isoforms$392,500
R01 · FY2011 · HL · contact PI
RETINAL CELL REMODELING UTILIZING ADVANCED IMAGING TECHNOLOGY$37,024
P41 · FY2011 · RR · contact PI
Tissue Hypoxia in Cardiac Morphogenesis$392,500
R01 · FY2010 · HL · contact PI
Smooth Muscle Myosin Phosphatase Subunit Isoforms$392,500
R01 · FY2010 · HL · contact PI
RETINAL CELL REMODELING UTILIZING ADVANCED IMAGING TECHNOLOGY$23,907
P41 · FY2010 · RR · contact PI
Cardiac Outflow Tract Remodeling by Myocyte Apoptosis$326,412
R01 · FY2008 · HL · contact PI
Smooth Muscle Myosin Phosphatase Subunit Isoforms$290,143
R01 · FY2008 · HL · contact PI
Cardiac Outflow Tract Remodeling by Myocyte Apoptosis$326,412
R01 · FY2007 · HL · contact PI
Smooth Muscle Myosin Phosphatase Subunit Isoforms$290,143
R01 · FY2007 · HL · contact PI
Cardiac Outflow Tract Remodeling by Myocyte Apoptosis$336,161
R01 · FY2006 · HL · contact PI
Smooth Muscle Myosin Phosphatase Subunit Isoforms$298,809
R01 · FY2006 · HL · contact PI
NEURONAL REMODELING AFTER RETINAL DETACHMENT AND DURING RECOVERY$1,009
P41 · FY2006 · RR · contact PI
Cardiac Outflow Tract Remodeling by Myocyte Apoptosis$382,500
R01 · FY2005 · HL
Smooth Muscle Myosin Phosphatase Subunit Isoforms$331,000
R01 · FY2005 · HL
CARDIAC OUTFLOW TRACT REMODELING BY MYOCYTE APOPTOSIS$306,000
R01 · FY2004 · HL
SMOOTH MUSCLE MYOSIN PHOSPHATASE SUBUNIT ISOFORMS$267,750
R01 · FY2004 · HL
CARDIAC OUTFLOW TRACT REMODELING BY MYOCYTE APOPTOSIS$306,000
R01 · FY2003 · HL
SMOOTH MUSCLE MYOSIN PHOSPHATASE SUBUNIT ISOFORMS$267,750
R01 · FY2003 · HL
CARDIAC OUTFLOW TRACT REMODELING BY MYOCYTE APOPTOSIS$306,000
R01 · FY2002 · HL
SMOOTH MUSCLE MYOSIN PHOSPHATASE SUBUNIT ISOFORMS$267,750
R01 · FY2002 · HL
CARDIAC OUTFLOW TRACT REMODELING BY MYOCYTE APOPTOSIS$306,000
R01 · FY2001 · HL
SMOOTH MUSCLE MYOSIN PHOSPHATASE SUBUNIT ISOFORMS$267,750
R01 · FY2001 · HL
CARDIAC OUTFLOW TRACT REMODELING BY MYOCYTE APOPTOSIS$292,750
R01 · FY2000 · HL